Warning: The NCBI web site requires JavaScript to function. more...

Sign in to NCBI

Result Filters

We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

J Biomed Opt. 2008 May-Jun;13(3):030507. doi: 10.1117/1.2939068.

Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy.

Lee TK, Baron ED, Foster TH.

Source

University of Rochester, Institute of Optics and Department of Imaging Sciences, Rochester, New York 14642, USA.

Abstract

Silicon phthalocyanine Pc 4 photodynamic therapy (Pc 4-PDT) has emerged as a potentially effective treatment for cutaneous T-cell lymphoma (CTCL). Noninvasive reflectance and fluorescence spectroscopy before, during, and after PDT may provide useful dose metrics and enable therapy to be tailored to individual lesions. We present the design and implementation of a portable bedside spectroscopy system for initial clinical trials of Pc 4-PDT of CTCL. Reflectance and fluorescence spectra were obtained from an early stage CTCL patient throughout the course of the PDT treatment. Preliminary patient data show a significant effect of Pc 4 on the tissue absorption, modest Pc 4 photobleaching, and heterogeneity of Pc 4 within and between the lesions.

PMID:: 18601524; [PubMed - indexed for MEDLINE]
PMCID:: PMC2527126

Free PMC Article

Images from this publication.See all images (4)Free text

Fig. 1

Fig. 3

Fig. 2

Fig. 4

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Research Support, N.I.H., Extramural

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Icon for Silverchair Information Systems

Icon for PubMed Central

Save items

loading

Click here to read article using PubReader

Related citations in PubMed

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial. [Lasers Surg Med. 2010]
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.
Baron ED, Malbasa CL, Santo-Domingo D, Fu P, Miller JD, Hanneman KK, Hsia AH, Oleinick NL, Colussi VC, Cooper KD. Lasers Surg Med. 2010 Dec; 42(10):728-35.
Immunosuppressive effects of silicon phthalocyanine photodynamic therapy. [Photochem Photobiol. 1999]
Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.
Reddan JC, Anderson CY, Xu H, Hrabovsky S, Freye K, Fairchild R, Tubesing KA, Elmets CA. Photochem Photobiol. 1999 Jul; 70(1):72-7.
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. [Clin Cancer Res. 2000]
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
Whitacre CM, Feyes DK, Satoh T, Grossmann J, Mulvihill JW, Mukhtar H, Oleinick NL. Clin Cancer Res. 2000 May; 6(5):2021-7.
Review Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. [Toxicol Appl Pharmacol. 2007]
Review Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.
Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, Oleinick NL. Toxicol Appl Pharmacol. 2007 Nov 1; 224(3):290-9. Epub 2007 Feb 15.
Review Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. [Clin Exp Dermatol. 2002]
Review Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma.
Leman JA, Dick DC, Morton CA. Clin Exp Dermatol. 2002 Sep; 27(6):516-8.

See reviews... See all...

Cited by 2 PubMed Central articles

Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome. [Adv Hematol. 2010]
Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome.
Lam M, Lee Y, Deng M, Hsia AH, Morrissey KA, Yan C, Azzizudin K, Oleinick NL, McCormick TS, Cooper KD, et al. Adv Hematol. 2010; 2010:896161. Epub 2010 Dec 12.
Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals. [Transl Oncol. 2010]
Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals.
Foster TH, Giesselman BR, Hu R, Kenney ME, Mitra S. Transl Oncol. 2010 Apr; 3(2):135-41.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymp...
Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy.
J Biomed Opt. 2008 May-Jun ;13(3):030507. doi: 10.1117/1.2939068.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk